Devon, living with FCS and Fin, father and caregiver
Patients & Caregivers
Where Science Meets Life
We are committed to researching and developing medications in cardiometabolic, pulmonary, liver, neuromuscular, and other therapeutic areas, bringing hope to those who need it most.
Jill, founder of Action FCS & living with FCS, and Jon, husband & caregiver
Patient Centricity & Advocacy
Together with advocacy organizations, we’re amplifying voices, raising awareness, addressing needs of the communities we serve, and developing therapies that make a real difference in people’s lives.
Learn More
Fin, father & caregiver, and Devon, living with FCS
Patient Stories
Hear from real patients living with FCS as they share their journeys of diagnosis, treatment, and hope. Discover how these individuals and families are reclaiming their lives and becoming advocates for better care.
Learn MorePlozasiran Expanded Access Program (EAP) for Familial Chylomicronemia Syndrome (FCS)
The plozasiran SHTG EAP is for individuals with severe hypertriglyceridemia at high risk of acute pancreatitis events, and may not be available in all countries.
About Arrowhead
We’re taking on hard-to-treat diseases by silencing the genes that cause them.
Learn More
Spotlight on FCS Paper
Providing perspectives from patients and caregivers who experience living with Familial Chylomicronemia Syndrome (FCS).
Read the Paper
Our Medicines
We aim to serve the unmet needs of patients throughout Canada with Health Canada-approved medicines.
Learn More